NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1061210049

Registered date:12/11/2021

Survey on the SARS-CoV-2 additional vaccination

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedSevere acute respiratory syndrome coronavirus 2
Date of first enrollment15/11/2021
Target sample size1500
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeTransition of SARS-CoV-2 serum antibody titer after the SARS-CoV-2 additional vaccination
Secondary OutcomeTransition ofHealth condition after the SARS-CoV-2 additional vaccination Backgroud factor that is contribute transition of SARS-CoV-2 serum antibody titer

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteriaSchool staff who are participating in jRCT1061200057 research and receive the additional SARS-CoV-2 vaccination in December 2021
Exclude criteriaNone

Related Information

Contact

Public contact
Name Shin Ohira
Address 577 Mastushima, Kurashiki city, Okayama prefecture Okayama Japan 701-0192
Telephone +81-86-462-1111
E-mail ohira@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School Hospital
Scientific contact
Name Takashi Nakano
Address 2-6-1 Nakasange, Kita-ku, Okayama city, Okayama prefecture Okayama Japan 700-8505
Telephone +81-86-225-2111
E-mail nakano@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School General Medical Center